JHS Svendgaard Laboratories Ltd

At Rs 7.90, sellers were still queuing — but there were no buyers willing to take the other side. JHS Svendgaard Laboratories Ltd locked at its lower circuit of 7.41% on 8 Jun 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

JHS Svendgaard Laboratories Ltd., the Himachal Pradesh-based oral care products manufacturer, reported a disappointing fourth quarter for FY26, posting a net loss of ₹3.57 crores despite achieving its highest quarterly revenue in recent years. The loss widened dramatically by 551.90% quarter-on-quarter and remained 48.71% higher year-on-year, raising serious concerns about the company's operational efficiency and profitability trajectory. With a market capitalisation of just ₹83.00 crores and shares trading at ₹9.29, the stock has underperformed significantly, declining 35.49% over the past year whilst the broader market fell only 6.97%.

JHS Svendgaard Laboratories Ltd, a micro-cap player in the FMCG sector, has reported a flat financial performance for the quarter ended March 2026, signalling a notable shift from its previously positive growth trajectory. Despite achieving its highest quarterly net sales to date, the company’s profitability metrics have deteriorated sharply, raising concerns about margin pressures and operational challenges in a competitive market environment.

At Rs 9.53, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JHS Svendgaard Laboratories Ltd locked at its upper circuit of 5% on 27 May 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 9.08, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JHS Svendgaard Laboratories Ltd locked at its upper circuit of 4.97% on 26 May 2026, with buyers queuing and no sellers willing to part with shares.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 26 May 2026, providing investors with the latest insights into its performance and prospects.

At Rs 8.97, the buying was done — not because demand dried up, but because the exchange wouldn't allow the stock to rise further. JHS Svendgaard Laboratories Ltd locked at its upper circuit of 5% on 21 May 2026, with buyers queuing and no sellers willing to part with shares in a session marked by thin liquidity and subdued volume.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 May 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.

At Rs 8.38, sellers were still queuing — but there were no buyers willing to take the other side. JHS Svendgaard Laboratories Ltd locked at its lower circuit of 5% on 5 May 2026, with unfilled sell orders and a frozen price, underscoring persistent selling pressure in a micro-cap stock with limited liquidity.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with the latest insights into its performance and outlook.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 01 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

For the fifth consecutive session, JHS Svendgaard Laboratories Ltd has closed lower, hitting a fresh 52-week low of Rs 6.15 on 30 Mar 2026, marking a steep decline from its 52-week high of Rs 16.20.

Despite a broadly positive market environment, JHS Svendgaard Laboratories Ltd has plunged to a fresh 52-week low of Rs 6.4 on 27 Mar 2026, extending its downward trajectory amid persistent selling pressure.

A sharp decline in JHS Svendgaard Laboratories Ltd has pushed the stock to a fresh 52-week low of Rs 7.12 on 23 Mar 2026, marking a 10.44% drop on the day and extending a downward trend that has seen the share price fall by nearly 42% over the past year. This underperformance stands in stark contrast to the broader market, with the Sensex down just 4.93% over the same period.